4//SEC Filing
Grissinger Michael 4
Accession 0001104659-23-095020
CIK 0001781983other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 9:51 PM ET
Size
18.1 KB
Accession
0001104659-23-095020
Insider Transaction Report
Form 4
Grissinger Michael
Director
Transactions
- Award
Common Stock
2023-08-23+500→ 799 total - Award
Stock Options (Right to Buy)
2023-08-23+2,000→ 2,000 totalExercise: $3.65Exp: 2033-08-23→ Common Stock (2,000 underlying)
Footnotes (2)
- [F1]These shares represent restricted stock units which were granted on August 23, 2023, and which will vest and be settled in common stock on August 23, 2024, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
- [F2]The option vests in full on August 23, 2024, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001757601
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 9:51 PM ET
- Size
- 18.1 KB